Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWLV
2626
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $5.7M | ﹤0.01% |
583,270
+10,159
| +2% | +$99.3K |
|
|
VERV
2627
DELISTED
Verve Therapeutics
VERV
| $5.68M | ﹤0.01% |
+371,671
| New | +$5.76M |
|
2628
Frontline
FRO
$9.84B
| $5.67M | ﹤0.01% |
+640,301
| New | +$5.8M |
|
|
ASPC
2629
DELISTED
Alpha Capital Acquisition Co
ASPC
| $5.67M | ﹤0.01% |
574,207
+65,469
| +13% | +$648K |
|
2630
Archer Aviation
ACHR
$4.43B
| $5.67M | ﹤0.01% |
1,839,471
+1,689,222
| +1,124% | +$6.8M |
|
2631
Valley National Bancorp
VLY
$7.69B
| $5.66M | ﹤0.01% |
543,858
-783,057
| -59% | -$9.3M |
|
2632
Millicom
TIGO
$15.7B
| $5.66M | ﹤0.01% |
393,912
+334,189
| +560% | +$6.86M |
|
|
NGM
2633
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5.66M | ﹤0.01% |
441,475
+24,059
| +6% | +$333K |
|
2634
CALL
Fortinet
FTNT
$122B
| $5.66M | ﹤0.01% |
+100,000
| New | +$5.94M |
|
|
APXI
2635
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
| $5.66M | ﹤0.01% |
565,000
+162,880
| +41% | +$1.63M |
|
|
CGAU
2636
Centerra Gold
CGAU
$4.59B
| $5.65M | ﹤0.01% |
833,765
+260,875
| +46% | +$2.21M |
|
|
MMAT
2637
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $5.65M | ﹤0.01% |
54,883
+54,633
| +21,853% | +$8.15M |
|
2638
iShares US Basic Materials ETF
IYM
$1.03B
| $5.65M | ﹤0.01% |
+48,000
| New | +$6.64M |
|
2639
RPM International
RPM
$13.6B
| $5.65M | ﹤0.01% |
71,746
-255,803
| -78% | -$21.5M |
|
2640
Bausch + Lomb
BLCO
$6.13B
| $5.64M | ﹤0.01% |
+370,130
| New | +$6M |
|
|
CERE
2641
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.62M | ﹤0.01% |
+212,600
| New | +$6.04M |
|
|
BCYC
2642
Bicycle Therapeutics
BCYC
$294M
| $5.6M | ﹤0.01% |
333,701
+170,334
| +104% | +$3.59M |
|
2643
PUT
Ametek
AME
$54.2B
| $5.58M | ﹤0.01% |
+50,800
| New | +$6.17M |
|
2644
CALL
Antero Resources
AR
$11.8B
| $5.58M | ﹤0.01% |
182,000
+134,000
| +279% | +$4.9M |
|
2645
Prothena Corp
PRTA
$479M
| $5.56M | ﹤0.01% |
204,670
-68,005
| -25% | -$1.99M |
|
2646
AEON Biopharma
AEON
$15.7M
| $5.55M | ﹤0.01% |
7,859
-35
| -0.4% | -$24.7K |
|
2647
CALL
Target
TGT
$74.1B
| $5.55M | ﹤0.01% |
39,300
-254,600
| -87% | -$48.8M |
|
2648
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
| $5.54M | ﹤0.01% |
54,156
-29,169
| -35% | -$2.99M |
|
2649
Duke Energy
DUK
$93.8B
| $5.54M | ﹤0.01% |
51,642
-711,201
| -93% | -$78.2M |
|
|
AGAC
2650
DELISTED
African Gold Acquisition Corp
AGAC
| $5.54M | ﹤0.01% |
565,360
+41,382
| +8% | +$405K |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.